Literature DB >> 3370165

[Histopathological study of the "cholesterol granuloma reaction" in the sellar and juxta-sellar tumors].

K Shirataki1, S Okada, S Matsumoto.   

Abstract

Specimens from operation of 211 sellar and juxta-sellar tumors were observed histopathologically, and discussed about the true form of "cholesterol granuloma reaction" in those tumors. Depending on the characteristic histological feature, "cholesterol granuloma reaction" was classified into 3 groups, each of which also represented a step of process of organization. Group I (cholesterol clefts predominates in hemorrhagic and necrotic foci), group II (foreign body giant cells, macrophages, round cell infiltrations are present other than cholesterol clefts, signifying active organization), group III (numerous cholesterol clefts predominates in fibrous scar tissue). Feature of "cholesterol granuloma reaction" were seen in 6 cases among 37 cases of craniopharyngioma with verified histology (16%), 8 among 165 in pituitary adenomas (5%) and 1 among 5 in pituitary epithelial cysts (20%). In addition, there were 4 cases in which histologic sections of the surgical specimen showed only the feature of "cholesterol granuloma reaction", in the absence of tumorous epithelial components. "Cholesterol granuloma reaction" is thought to develop as a secondary reaction to hemorrhage or tissue necrosis (pituitary adenomas), or to keratinization (craniopharyngiomas). In occasions in which surgical specimen show only a feature of "cholesterol granuloma reaction", making the final diagnosis is necessary to be careful, taking account of other lesions as well as craniopharyngiomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370165

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  9 in total

1.  Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction.

Authors:  Hiroshi Nishioka; Makoto Shibuya; Kuninori Ohtsuka; Yukio Ikeda; Jo Haraoka
Journal:  Neuroradiology       Date:  2010-03-18       Impact factor: 2.804

Review 2.  Cholesterol granulomas presenting as sellar masses: a similar, but clinically distinct entity from craniopharyngioma and Rathke's cleft cyst.

Authors:  Raúl A Hernández-Estrada; Varun R Kshettry; Ashley N Vogel; Mark T Curtis; James J Evans
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

3.  Xanthogranulomatous pituitary adenoma: A case report and literature review.

Authors:  Guihong Li; Chaochao Zhang; Yuxue Sun; Qingchun Mu; Haiyan Huang
Journal:  Mol Clin Oncol       Date:  2018-01-10

4.  Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report.

Authors:  Takamasa Nishiuchi; Koji Murao; Hitomi Imachi; Yoshio Kushida; Reiji Haba; Nobuyuki Kawai; Takashi Tamiya; Toshihiko Ishida
Journal:  J Med Case Rep       Date:  2012-04-29

5.  Primary ectopic frontotemporal craniopharyngioma.

Authors:  Luis Alberto Ortega-Porcayo; Juan Antonio Ponce-Gómez; Mauricio Martínez-Moreno; Lesly Portocarrero-Ortíz; Martha Lilia Tena-Suck; Juan Luis Gómez-Amador
Journal:  Int J Surg Case Rep       Date:  2015-01-08

6.  Two children with xanthogranuloma of the sellar region.

Authors:  Toshihiro Tajima; Yutaka Sawamura; Katsura Ishizu; Jyunko Tsubaki
Journal:  Clin Pediatr Endocrinol       Date:  2006-08-02

7.  Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.

Authors:  R Ved; N Logier; P Leach; J S Davies; C Hayhurst
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

8.  Sellar xanthogranuloma: A diagnostic challenge.

Authors:  Ahoud Alharbi; Ali Alkhaibary; Abeer Alaglan; Sami Khairy; Zahra Alkhunaizi; Fahd AlSufiani; Ali H Alassiri; Ahmed Alkhani
Journal:  Surg Neurol Int       Date:  2022-03-04

Review 9.  Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare Inflammatory Entity.

Authors:  Vera Lozovanu; Carmen Emanuela Georgescu; Lavinia Maria Florescu; Carmen Georgiu; Horatiu Silaghi; Andrian Fratea; Cristina Alina Silaghi
Journal:  J Pers Med       Date:  2022-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.